TriVascular Technologies prices IPO at $12, below the range

By
A A A

TriVascular Technologies, which markets the smallest and most versatile stent grafts for endovascular aortic repair, raised $78 million by offering 6.5 million shares at $12, below the range of $13 to $15. TriVascular Technologies will list on the NASDAQ under the symbol TRIV. The company initially filed confidentially on December 16, 2013. J.P. Morgan and Credit Suisse acted as joint bookrunners on the deal.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: TRIV

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Quick on Your Feet
Quick on Your Feet                  
Early Entrepreneurship
Early Entrepreneurship              

Stocks

Referenced

100%

Most Active by Volume

48,099,947
  • $16.09 ▲ 0.50%
40,277,806
  • $102.50 ▲ 0.24%
40,236,499
  • $19.57 ▲ 2.35%
31,092,510
  • $49.75 ▲ 0.65%
30,795,218
  • $34.92 ▲ 0.78%
29,910,855
  • $3.63 ▲ 0.83%
24,019,154
  • $13.06 ▼ 0.38%
23,753,906
  • $74.82 ▲ 1.31%
As of 8/29/2014, 04:04 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com